Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with elevated PSA (4-20 ng/mL), or those with suspicious prostate lesions indicated by digital rectal examination/ultrasound; 2. No history of prostate biopsy; 3. Planned to undergo MRI examination and transperineal targeted biopsy.
Exclusion criteria
Exclusion criteria: 1. Patients with a confirmed diagnosis of prostate cancer; 2. Contraindications to biopsy (such as acute prostatitis, coagulation dysfunction, etc.); 3. Patients unable to cooperate with MRI examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Positive rate of targeted biopsy;Detection rate of clinically significant prostate cancer;MRI image quality score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Consistency between PIRADS Score and Pathological Results ;Number of Positive Biopsy Cores and Tumor Proportion;Lesion Detection Ability in Different Prostate Regions;Inter-Observer Agreement in Imaging Scoring;Comparison of Detection Rates Between Targeted Biopsy and Systematic Biopsy; | — |
Countries
China
Contacts
Zhongda Hospital, Southeast University